FRACASSO, Giulio

FRACASSO, Giulio  

DIPARTIMENTO DI MEDICINA  

Mostra records
Risultati 1 - 20 di 83 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 1-gen-2004 Castelletti, Deborah; Fracasso, Giulio; Righetti, Sabrina; Tridente, Giuseppe; Schnell, R.; Engert, A.; Colombatti, Marco
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 1-gen-2018 Litti, Lucio; Rivato, Niccolò; Fracasso, Giulio; Bontempi, Pietro; Nicolato, Elena; Marzola, Pasquina; Venzo, Alfonso; Colombatti, Marco; Gobbo, Marina; Meneghetti, Moreno
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 1-gen-2013 Frigerio, B; Fracasso, Giulio; Luison, E; Cingarlini, Sara; Mortarino, M; Coliva, A; Seregni, E; Bombardieri, E; Zuccolotto, G; Rosato, A; Colombatti, Marco; Canevari, S; Figini, M.
Acute sarcomeric M-Line Disease associated with ATP synthase subunit α autoantibodies in ankylosing spondylitis 1-gen-2018 Guglielmi, Valeria; Vattemi, Gaetano; Cecconi, Daniela; Fracasso, Giulio; Marini, Matteo; Tomelleri, Giuliano
An electrochemiluminescent-supramolecular approach to sarcosine detection for early diagnosis of prostate cancer. 1-gen-2015 Giovanni, Valenti; Enrico, Rampazzo; Biavardi, Elisa; Villani, Elena; Fracasso, Giulio; Marcaccio, Massimo; Bertani, Federico; Ramarli, Dunia; Dalcanale, Enrico; Paolucci, Francesco; Luca, Prodi
Anti PSMA immunotoxins activity against prostate cancer cell lines. 1-gen-2002 T., Prayer Galetti; F., Pagano; Fracasso, Giulio; Cingarlini, Sara; Bellisola, Giuseppe; Righetti, Sabrina; Chiesa, Elena; Colombatti, Marco
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer 1-gen-2020 Monia Montagner, Isabella; Penna, Alessandro; Fracasso, Giulio; Carpanese, Debora; Dalla Pietà, Anna; Barbieri, Vito; Zuccolotto and Antonio Rosato, Gaia
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 1-gen-2002 Fracasso, G.; Bellisola, G.; Cingarlini, S.; Castelletti, D.; Tommaso, Prayer-Galetti; Pagano, F.; Tridente, G.; Colombatti, M.
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 1-gen-2006 Castelletti, Deborah; Fracasso, Giulio; Alfalah, M.; Cingarlini, Sara; Colombatti, Marco; Naim, H. y.
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 1-gen-2012 Susanne, Lütje; Gerben, Franssen; Wijnand, Helfrich; Fracasso, Giulio; Colombatti, Marco; Catharina van, Rij; Wim, Oyen; Otto, Boerman
Characterization of an In-111-labeled anti-PSMA antibody-photosensitizer conjugate for targeted photodynamic therapy of PSMA-expressing tumors 1-gen-2017 Lutje, S; Heskamp, S; Franssen, G; Hekman, M; Fracasso, Giulio; Rijpkema, M; Gotthardt, M; Herrmann, K; Boerman, O.
Characterization of In-111-labeled site-specifically conjugated anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors 1-gen-2017 Lutje, S; Gerrits, D; Molkenboer-Kuenen, Jd; Herrmann, K; Fracasso, G; Colombatti, M; Boerman, Oc; Heskamp, S
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors 1-gen-2018 Lütje, Susanne; Gerrits, Danny; Molkenboer-Kuenen, Janneke D; Herrmann, Ken; Fracasso, Giulio; Colombatti, Marco; Boerman, Otto C; Heskamp, Sandra
Cloning and characterisation of canine prostate-specific membrane antigen 1-gen-2013 Schmidt, S.; Fracasso, Giulio; Colombatti, Marco; Naim, H. Y.
Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA) 1-gen-2014 J., Tykvart; V., Navrátil; F., Sedlák; E., Corey; Colombatti, Marco; Fracasso, Giulio; F., Koukolík; C., Bařinka; P., Šácha; J., Konvalinka
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 1-gen-2005 Colombara, Michaela; Antonini, Valeria; Riviera, Ap; Mainiero, F; Strippoli, R; Merola, Marcello; Fracasso, Giulio; Poffe, Ornella; Brutti, N; Tridente, Giuseppe; Colombatti, Marco; Ramarli, D.
CT-227 Dual CAR-Engineered NK92 Cells: An Off-the-Shelf Cell Therapy for Cancer 1-gen-2022 Zuccolotto, Gaia; Penna, Alessandro; Fracasso, Giulio; Santa, Silvia Dalla; Carpanese, Debora; Montagner, Isabella Monia; Rossi, Valentina; Tosi, Anna; Rosato, Antonio
D2B antibody and its scFvD2B fragment in nanomedicine: promising tools in the theranostics of prostate cancer 1-gen-2021 Mitri, Nadim; Rahme, Kamil; Fracasso, Giulio; Ghanem, Esther
D2B-Functionalized Gold Nanoparticles: Promising Vehicles for Targeted Drug Delivery to Prostate Cancer 1-gen-2023 Sarkis, Monira; Minassian, Georges; Mitri, Nadim; Rahme, Kamil; Fracasso, Giulio; El Hage, Roland; Ghanem, Esther
Design and Evaluation of 223Ra-Labeled and Anti-{PSMA} Targeted {NaA} Nanozeolites for Prostate Cancer Therapy{ extemdash}Part {II}. Toxicity, Pharmacokinetics and Biodistribution 1-gen-2021 Lankoff, Anna; Czerwìnska, Malwina; Walczak, Rafal; Karczmarczyk, Urszula; Tomczyk, Kamil; Brzòska, Kamil; Fracasso, Giulio; Garnuszek, Piotr; Mikolajczak, Renata; Kruszewski, Marcin